<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01209429</url>
  </required_header>
  <id_info>
    <org_study_id>M-20100150</org_study_id>
    <nct_id>NCT01209429</nct_id>
  </id_info>
  <brief_title>Importance of the GH/IGF-1 Axis for Human Substrate and Energy Metabolism During Calorie Restriction</brief_title>
  <official_title>Importance of the GH/IGF-1 Axis for Human Substrate and Energy Metabolism During Calorie Restriction</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Aarhus</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Aarhus</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study will investigate whether growth hormone is modulated by the enzyme SIRT1 and by
      that is stimulating lipolysis on expense of IGF-I production. This is done in 10 healthy men
      on calorie restriction on 4 study days with fat and skeletal muscle biopsies.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      It has been shown that calorie restriction enhances the length of life in yeast, worms, fish
      and rodent. Whether this elongation of life due to calorie restriction can be applied to
      humans is not known. However, it is a fact that calorie restriction will decrease the risk of
      developing metabolic disturbances such as diabetes, hypertension and atherosclerosis.

      On the molecular level the specific relations are not fully understood. This study will
      investigate the possible connection between SITR1 and the relation to the GH/IGF-I axis and
      STAT5b in healthy men. The participant will fast 42 and 12 hours respectively, and have GH or
      placebo infusions. The design is a classical 2x2 design and will be randomized.

      Knowledge of the interactions between calorie restriction, SIRT1, STAT5b and the GH/IGF-I
      axis will apply important information about the relations between aging, energy metabolism
      and metabolic disturbances.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>September 2010</start_date>
  <completion_date type="Actual">September 2011</completion_date>
  <primary_completion_date type="Actual">September 2011</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Factorial Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Description of intracellular pathways to clarify the interplay between calorie restriction, SIRT1, STATb5, and the GH/IGF-I axis</measure>
    <time_frame>6 hour study days</time_frame>
    <description>All study days consists of 3 hour basic periods and 3 hours hyperinsulinemic, euglycemic clamp.</description>
  </primary_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Anticipated">10</enrollment>
  <condition>Healthy</condition>
  <arm_group>
    <arm_group_label>42 hour fast/GH infusion</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>42 hour fast/Placebo infusion</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>12 hour fast/GH infusion</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>12 hour fast/Placebo infusion</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>GH hormone infusion</intervention_name>
    <description>Norditropin 30 ng/kg/min</description>
    <arm_group_label>42 hour fast/GH infusion</arm_group_label>
    <arm_group_label>12 hour fast/GH infusion</arm_group_label>
    <other_name>Norditropin</other_name>
    <other_name>Genotropin</other_name>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>42 hour fast</intervention_name>
    <description>The participant will be fasting 42 hours prior to the start of the study day, drinking water is allowed</description>
    <arm_group_label>42 hour fast/GH infusion</arm_group_label>
    <arm_group_label>42 hour fast/Placebo infusion</arm_group_label>
    <other_name>No other name</other_name>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>12 hour fast</intervention_name>
    <description>12 hour fast will be used as a control scenario to 42 hour fast</description>
    <arm_group_label>12 hour fast/GH infusion</arm_group_label>
    <arm_group_label>12 hour fast/Placebo infusion</arm_group_label>
    <other_name>No other name</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  healthy lean men

          -  age &gt;18

        Exclusion Criteria:

          -  metabolic disturbances

          -  alcohol drug abuse

          -  malign disease: current or previous
      </textblock>
    </criteria>
    <gender>Male</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jens Otto L JÃ¸rgensen, Professor</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Hospital of Aarhus</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University Hospital of Aarhus, Norrebrogade</name>
      <address>
        <city>Aarhus</city>
        <zip>8000</zip>
        <country>Denmark</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Denmark</country>
  </location_countries>
  <verification_date>September 2011</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 24, 2010</study_first_submitted>
  <study_first_submitted_qc>September 24, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 27, 2010</study_first_posted>
  <last_update_submitted>September 12, 2011</last_update_submitted>
  <last_update_submitted_qc>September 12, 2011</last_update_submitted_qc>
  <last_update_posted type="Estimate">September 13, 2011</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Aarhus</investigator_affiliation>
    <investigator_full_name>Birgitte Nellemann</investigator_full_name>
    <investigator_title>MD PhD student</investigator_title>
  </responsible_party>
  <keyword>Calorie restriction</keyword>
  <keyword>GH/IGF-I axis</keyword>
  <keyword>STATb5</keyword>
  <keyword>SIRT1</keyword>
  <keyword>Intracellular signaling peptides and proteins</keyword>
  <keyword>Fasting</keyword>
  <keyword>Growth hormone</keyword>
  <keyword>IGF-1</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hormones</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

